At KAMBIS, our commitment to patient safety and product consistency is validated by rigorous, third-party oversight. We are proud to announce that our cultivation facility has successfully passed the 2026 renewal assessment for International GACP certification. This achievement is not merely a regulatory requirement; it is a testament to our unwavering dedication to maintaining a pharmaceutical-grade supply chain for the global medical market.
A GACP renewal assessment is a comprehensive audit of every biological and operational variable within our facility. To maintain this international standard, KAMBIS must demonstrate absolute adherence to specialized protocols, including:
- Genetic Traceability
- Environmental Standardization (such as climate, irrigation, and light cycles)
- Hygienic Integrity
International certification is the bridge that connects local excellence with global demand. By successfully renewing our GACP status, KAMBIS remains at the forefront of the export sector, capable of meeting the stringent import requirements of the European Union and other highly regulated international regions.
